BidaskClub upgraded shares of LifePoint Health (NASDAQ:LPNT) from a sell rating to a hold rating in a report published on Tuesday morning.

Several other equities research analysts also recently weighed in on the company. Royal Bank of Canada downgraded LifePoint Health from an outperform rating to a sector perform rating and set a $65.00 price target for the company. in a report on Tuesday, July 24th. William Blair reissued a hold rating on shares of LifePoint Health in a report on Friday, August 17th. BMO Capital Markets raised their price target on LifePoint Health from $62.00 to $65.00 and gave the stock a market perform rating in a report on Tuesday, July 24th. Mizuho set a $65.00 price target on LifePoint Health and gave the stock a hold rating in a report on Monday, July 23rd. Finally, Credit Suisse Group raised their price target on LifePoint Health from $58.00 to $65.00 and gave the stock a neutral rating in a report on Tuesday, July 24th. One analyst has rated the stock with a sell rating, fifteen have given a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. LifePoint Health presently has a consensus rating of Hold and an average target price of $59.57.

Shares of NASDAQ LPNT opened at $64.40 on Tuesday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.85 and a quick ratio of 1.63. The stock has a market capitalization of $2.49 billion, a price-to-earnings ratio of 17.74, a price-to-earnings-growth ratio of 1.62 and a beta of 0.64. LifePoint Health has a fifty-two week low of $41.45 and a fifty-two week high of $65.35.

LifePoint Health (NASDAQ:LPNT) last issued its quarterly earnings results on Friday, July 27th. The company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.08 by $0.19. The business had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. LifePoint Health had a return on equity of 7.04% and a net margin of 0.65%. The company’s quarterly revenue was down 1.6% on a year-over-year basis. During the same quarter last year, the company earned $0.96 earnings per share. On average, equities analysts anticipate that LifePoint Health will post 4.63 earnings per share for the current year.

Several institutional investors have recently added to or reduced their stakes in LPNT. Point72 Asia Hong Kong Ltd lifted its holdings in shares of LifePoint Health by 1,897.5% during the first quarter. Point72 Asia Hong Kong Ltd now owns 2,417 shares of the company’s stock worth $114,000 after purchasing an additional 2,296 shares during the period. Bank of Montreal Can acquired a new stake in shares of LifePoint Health during the second quarter worth about $169,000. Cerebellum GP LLC purchased a new position in LifePoint Health during the third quarter valued at approximately $178,000. Campbell & CO Investment Adviser LLC purchased a new position in LifePoint Health during the second quarter valued at approximately $211,000. Finally, Dynamic Technology Lab Private Ltd purchased a new position in LifePoint Health during the second quarter valued at approximately $219,000.

About LifePoint Health

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Recommended Story: Conference Calls and Individual Investors

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.